|
Resources and News continued...
The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong? (19 July 2005) - From PLoS Medicine, a look at the debate around closed PrEP trials, questions that have arisen and what can be done to avoid problems in the future
Media reporting of tenofovir trials in Cambodia and Cameroon - BMC International Health and Human Rights, (24 August 2005)
Finding the Community in "Community Consultation" to Prepare for Biomedical HIV Prevention Trials - abstract from CROI 2006
Anticipating the efficacy of HIV pre-exposure prophylaxis (PrEP) and the needs of at-risk Californians (November 2004)
HIV Research and Access to Treatment (13 January 2006) - AVAC letter to Science and response from Grant et. al.
We Must Not Let Protestors Derail Trials
of Pre-Exposure Prophylaxis for HIV (September 2005) - opinion piece in PLoS Medicine
Unethical clinical trials in
Thailand: a community
response - letter to the Lancet (7 May 2005)
Promote HIV Chemoprophylaxis
Research, Don’t Prevent It (30 September 2005) - from Science
A public statement from the Global Campaign for Microbicides and AVAC on the impact of stopping Tenofovir trials in Cambodia and Cameroon (February 18, 2005)
Phase 2 trial of Oral tenofovir use as a chemoprophylaxis for HIV infection in Nigeria: The outcome of community involvement with the scientific research process - A report from the Nigeria HIV Vaccine and Microbicide Advocacy Group
|
